Pfizer

Open: 27.18 Close: 26.93 Change: -0.25

15 things an AI found about Pfizer Company Inc that you should know before investing.

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, company, quarter, profit, revenue, recent, earnings, and the …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer Inc. adjusted earnings were 10 cents a share, Pfizer said, while Wall Street had expected a 19-cent loss. Cantor Fitzgerald maintained a Buy rating on Pfizer with a price target of $45.00. Pfizer CEO Albert Bourla said RSV vaccine Abrysvo was a “bad launch” for company.

Today's News

Pfizer posted a surprise adjusted fourth-quarter profit as the companys declining Covid business lost less revenue than expected. Pfizer also reiterated its full-year 2024 guidance. Pfizer CEO Albert Bourla said RSV vaccine Abrysvo was a “bad launch” for the company. Pfizer execs shared muted enthusiasm for recent progress the company has made with its rollout. Company blamed lower demand and “unfavorable timing of customer orders” Pfizer reported a quarterly revenue of $1323 billion and net loss of $238 billion. Pfizer Inc. adjusted earnings were 10 cents a share, Pfizer said, while Wall Street had expected a 19-cent loss. Cantor Fitzgerald maintained a Buy rating on Pfizer with a price target of $45.00. Pfizer-BioNTech COVID-19 Vaccine shelf-life extensions Please see the most recent updates above. Pfizer Inc. markets closed S&P 500 4,958.61 +52.42 (+1.42%) Dow 30 38,654.42 +134.58 (+134.07%) Nasdaq 15,628.95 +267.31 +1.74%) Russell 2000 1,962.73 -11.69 (-0.69%) Crude Oil 72.41 -1, 411 Big MS pointing stays ran horns precisely Pl facult intimacy� fries Pfizer CEO Albert Bourla sits down with Yahoo Finance to discuss all things Pfizer from its recent quarterly earnings, its acquisition of Seagen, and what lies ahead for the company. Pfizer surprised Wall Street this morning with an unexpected profit beat in its fourth quarter. Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast. Pfizer lost $3.37 billion in the final quarter of 2023 after booking a nearly $5 billion profit in the same quarter the prior year. Total revenue fell 41% in the quarter to $14.25 billion.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

This document will help you to evaluate Pfizer without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, company, quarter, profit, revenue, recent, earnings, and the most common words in the summary are: pfizer, bloomberg, stock, vaccine, best, business, product, . One of the sentences in the summary was: adjusted earnings were 10 cents a share, Pfizer said, while Wall Street had expected a 19-cent loss. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #bloomberg #stock #vaccine #best #business #product.